Mint Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.50 M
as on 24-10-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 24-10-2024
- Satisfied Charges ₹ 2.59 Cr
as on 24-10-2024
- Revenue -6.67%
(FY 2023)
- Profit 461.02%
(FY 2023)
- Ebitda 169.87%
(FY 2023)
- Net Worth 41.01%
(FY 2023)
- Total Assets 3.38%
(FY 2023)
About Mint Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹2.59 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sidharath Goel and Punita Goel serve as directors at the Company.
- CIN/LLPIN
U24233HR2012PTC046713
- Company No.
046713
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Aug 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- LocationPanchkula, Haryana
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Mint Life Sciences Private Limited offer?
Mint Life Sciences Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Digestive Drugs, Common Disease Medicines, Pharmaceutical Medicine, Cleaning Liquids & Wipes, Disinfectant Spray, Antihistamines, Pharmaceutical Capsules, Nutraceuticals & Dietary Supplements, Mineral Supplement.
Who are the key members and board of directors at Mint Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sidharath Goel  | Director | 09-Aug-2012 | Current |
| Punita Goel | Director | 06-Jun-2021 | Current |
Financial Performance of Mint Life Sciences.
Mint Life Sciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.67% decrease. The company also saw a substantial improvement in profitability, with a 461.02% increase in profit. The company's net worth Soared by an impressive increase of 41.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mint Life Sciences?
In 2023, Mint Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Mar 2017 | ₹1.00 Cr | Open |
Hdfc Bank Limited Creation Date: 04 Aug 2018 | ₹2.59 Cr | Satisfied |
How Many Employees Work at Mint Life Sciences?
Unlock and access historical data on people associated with Mint Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mint Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mint Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
